29
Views
3
CrossRef citations to date
0
Altmetric
Drug Evaluation

Insulin lispro:a new quick-acting insulin analogue

Pages 1247-1256 | Published online: 23 Feb 2005

  • SACKEY AH, JEFFERSON IG: Interval between insulininjection and breakfast in diabetes. Arch. Dis. Childhood (1994) 71:248–250.
  • BRANGE J, OWENS DR, KANG S, VOLUND A: Monomericinsulins and their experimental and clinical implica-tions. Diabetes Care (1990) 13:923–954.
  • THE DIABETES CONTROL AND COMPLICATIONS TRIALRESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mel-litus. New Engl. J Merl. (1993) 329:977–986.
  • THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: Hypoglycemia in the Diabetes Con-trol and Complications Trial. Diabetes (1997) 46:271–286.
  • DREJER K: The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabe-tes/Metab. Rev. (1992) 8:259–285.
  • HOVVEY DC, BOWSHER RR, BRUNELLE RL, WOODWORTHJR: [Lys(B28), Pro(B29)]-human insulin. A rapidly ab-sorbed analogue of human insulin. Diabetes (1994) 43:396–402.
  • TER BRAAK EW, WOODWORTH JR, BIANCHI R et al: Injection site effects on the pharmacokinetics and glu-codynamics of insulin lispro and regular insulin. Dia-betes Care (1996) 19:1437–1440.
  • HEINEMANN L, HEISE T, WAHL LC et al.: Prandial glycae-mia after a carbohydrate-rich meal in Type 1 diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin. DiabeL Med. (1995) 13:625–629.
  • TORLEONE E, FANELLI C, RAMBOTTI AM: Pharmacokinet-ics, pharmacodynamics and glucose counter-regula-tion following subcutaneous injection of the monomeric insulin analogue [Lys(B28), Pro(B29)] in IDDM. Diabetologia (1994) 37:713–720.
  • JACOBS MA, SALOBIR P, POPP-SNIJDERS C, ADER H, HEINE RJ: Counter-regulatory hormone responses and symp-toms during hypoglycaemia induced by porcine, hu-man regular insulin and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male vol-unteers. Diabet. Med. (1997) 14:248–257.
  • MCCRIMMON RJ, FRIER BM: A comparison of hypogly-caemia induced by human soluble insulin and lys-pro (LY275585) insulin. Diabetologia (1996) 39 (Suppl. 1):A217.
  • ANDERSON JH, Jr., BRUNELLE RL, KOIVISTO VA et al.: Improved mealtime treatment of diabetes mellitus us-ing an insulin analogue. Multicenter Insulin Lispro Study Group. Clin. Ther. (1997) 19:62–72.
  • ANDERSON JH, BRUNELLE RL, KOIVISTO VA et al. AND THE MULTICENTER INSULIN LISPRO STUDY GROUP: Re-duction of post-prandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin analog treatment. Diabetes (1997) 46:265–270.
  • ZINMAN B, TILDESLEY H, CHIASSON J-L, TSUI E, STRACK T: Insulin lispro in CSII. Results of a double-blind cross-over study. Diabetes (1997) 46:440–443.
  • ANDERSON JH, BRUNELLE RL, KEOHANE Petal.: Mealtime treatment with insulin analogue improves post-prandial hyperglycemia and hypoglycemia in NIDDM patients. Arch. Intern. Med. (1997) 157:1249–1255.
  • HOLLEMAN F, HOEKSTRA JBL: Insulin lispro. New. Engl.J. Med. (1997) 337:176–183.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.